Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 1 | |
Outperform | 3 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 4 analysts offering 12 month price targets for SAB Biotherapeutics Inc have a median target of 10.00, with a high estimate of 25.00 and a low estimate of 6.00. The median estimate represents a 264.96% increase from the last price of 2.74.
High | 812.4% | 25.00 |
Med | 265.0% | 10.00 |
Low | 119.0% | 6.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 12, 2024.
Average growth rate | -42.93% |
Average growth rate | -22.96% |
More ▼
Revenue history & estimates in USD
Average growth rate | +358.67% |
Average growth rate | -75.68% |
More ▼